tenk.fyi

Trevi Therapeutics, Inc.

TRVINasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$42.8M

10.8% YoY

EPS

$-0.32

31.9% YoY

Cash

$18.9M

44.5% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro